Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health-Reference-Cited by-同舟云学术

Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health

Published:1993-02 Issue:1 Volume:4 Page:39-69
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Oldfield Edward H.,Ram Zvi¹,Culver Kenneth W.²,Blaese R. Michael³,DeVroom Hetty L.⁴,Anderson W. French⁵

Affiliation:

1. Surgical Neurology Branch, NINDS

2. Senior Clinical Investigator, Metabolism Branch, DCBDC, NCI

3. Chief, Cellular Immunology Section, Metabolism Branch, DCBDC, NCI

4. SNB, NINDS

5. Chief, MHB, NHLBI

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1993.4.1-39

Cited by 390 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians;BMC Cancer;2024-04-25

2. Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health;Translational Medicine Communications;2023-04-10

3. Case report: Stem cell-based suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene reduces tumor progression in multifocal glioblastoma;Frontiers in Neurology;2023-03-22

4. Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies;Molecular Therapy - Methods & Clinical Development;2022-09

5. Targeted biallelic integration of an inducible Caspase 9 suicide gene for safer cellular therapies prevents development of drug-resistant escapees in human iPSCs;2021-09-19